Drug Profile
Paclitaxel-releasing balloon catheter - Blue Medical
Alternative Names: Protege DEB Catheter; Protege DEB NC; Protege non compliant DEB Catheter; Protégé; Protégé NCLatest Information Update: 15 Jan 2022
Price :
$50
*
At a glance
- Originator Blue Medical
- Class Antineoplastics; Diterpenes; Paclitaxels; Skin disorder therapies; Small molecules; Taxanes; Vascular disorder therapies
- Mechanism of Action Mitosis inhibitors; Tubulin polymerisation promoters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Coronary artery disease
Most Recent Events
- 30 Oct 2012 Registered for Coronary artery disease (non-compliant paclitaxel-eluting balloon incorporating Force® catheter) in European Union (Intracoronary)
- 20 Mar 2012 Launched for Coronary artery disease in European Union (Intracoronary) - first global launch
- 16 Nov 2010 Registered for Coronary artery disease (paclitaxel-eluting balloon incorporating Everest® catheter) in European Union (Intracoronary)